SPONSOR
Shanghai BDgene Co., Ltd.
Total Trials
2
Recruiting
2
Phases
N/A
NCT05776173
Recruiting
Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent β-thalassemia
β-thalassemia Major
NCT05773729
Recruiting
Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent Beta-thalassemia
β-thalassemia